Keywords: positive, results, genaera, squalamine, phase, iia, trial

Positive results for Genaera's squalamine in Phase IIa trial

Article | 27 May 2002

Print This

USA-based Genaera has reported positive final results for itsanti-angiogenic drug squalamine, which is in a Phase IIa non-small cell lung ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in